Remed Co

Remed Co Net Debt / EBITDA

The Net Debt to EBITDA of Remed Co (302550.KQ) as of Oct 19, 2026 is 3.72. In the previous year, Net Debt to EBITDA was -1.74 — a change of -314.06% (higher).

Net Debt / EBITDA

3.72

YoY

-314.06%

Last updated:

Net Debt to EBITDA of Remed Co is 2025 3.72 . Net Debt to EBITDA of Remed Co was 2024 -1.74 . It decreases by -314.06% higher compared to the previous year.

The Remed Co Net Debt / EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt / EBITDA
Date
Net Debt / EBITDA
Jan 1, 2017
3.90 KRW
Jan 1, 2018
-0.44 KRW
Jan 1, 2019
-2.06 KRW
Jan 1, 2020
-11.81 KRW
Jan 1, 2021
-13.04 KRW
Jan 1, 2023
6.32 KRW
Jan 1, 2024
-1.74 KRW
Jan 1, 2025
3.72 KRW
The Remed Co Net Debt / EBITDA history
YEARNet Debt / EBITDAYoY
3.72-314.06%
-1.74-127.51%
6.32-148.45%
-13.04+10.39%
-11.81+474.77%
-2.06+363.57%
-0.44-111.38%
3.90—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Remed Co Stock analysis

What does Remed Co do? Remed Co Ltd, headquartered in Daejeon, South Korea, is a Health Care sector company listed on 14 August 2018. The company manufactures and sells transcranial magnetic stimulation (TMS) therapy machines, pain therapy devices including electromagnetic stimulation and shockwave therapy equipment, and biosignal monitoring systems such as patient and fetal monitors. Its products are distributed domestically and internationally, serving both medical and therapeutic markets. Remed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remed Co stock

Net Debt to EBITDA of Remed Co is 3.72 in 2025.

Net Debt to EBITDA of Remed Co changed from -1.74 to 3.72, representing a -314.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to EBITDA Remed Co since 2006 – with annual values, charts, and detailed analysis.

Net Debt/EBITDA measures how many years it would take to repay all debt using EBITDA. Lower ratios indicate stronger debt repayment capacity.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to EBITDA's Remed Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Remed Co

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Remed Co